BNP Paribas Financial Markets
ARMP icon

BNP Paribas Financial Markets’s Armata Pharmaceuticals ARMP Stock Holding History

BNP Paribas Financial Markets’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-710
Closed -$4.46K – 5826
2025
Q4 		$4.46K Buy
+710
New +$3.89K ﹤0.01% 5273

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets's ARMP Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Armata Pharmaceuticals (ARMP) in Q1 2026, closing a stake of 710 shares — an estimated $4.46K sold.

BNP Paribas Financial Markets first reported a position in ARMP in Q4 2025 and held it in 1 quarter. The position peaked at $4.46K in Q4 2025. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Armata Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 710 Armata Pharmaceuticals shares in Q1 2026, an estimated $4.46K.
  • BNP Paribas Financial Markets first reported a position in Armata Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Armata Pharmaceuticals position peaked at $4.46K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.